Penis Enlargement Medical Consultation Questions: The 27-Question Checklist Experts Use
Introduction: Why Most Men Walk Into a Consultation Unprepared
Penis enlargement procedures span a significant spectrum—from minimally invasive hyaluronic acid filler injections to surgical interventions costing $10,000 to $20,000 or more. Complication profiles range equally wide, from minor bruising to permanent erectile dysfunction. The quality of the consultation is the single most predictive variable in determining which outcome a patient is more likely to experience.
Men who have privately researched this topic deserve a consultation framework that matches their analytical standards, not vague reassurances from marketing materials. This article delivers precisely that: a tiered, 27-question checklist organized by consultation phase, with concrete red-flag indicators for each category.
The landscape demands careful navigation. No major medical organization—not the American Urological Association (AUA), the Sexual Medicine Society of North America (SMSNA), nor the European Association of Urology (EAU)—formally endorses cosmetic penis enlargement for men with normal anatomy. This absence of institutional endorsement makes provider selection and consultation quality even more critical.
This checklist addresses dimensions that are consistently overlooked: psychological screening without stigma, FDA regulatory distinctions, and what a provider’s answer to “What if I’m unhappy?” reveals about their ethics.
How to Use This Checklist
The checklist follows a tiered structure across six consultation phases, each containing four to five questions with corresponding red-flag indicators. These questions serve dual purposes: gathering essential information and evaluating the provider’s competence, ethics, and transparency.
A provider who becomes defensive, dismissive, or evasive when asked these questions is providing critical information about their practice. Patients should consider printing or saving this checklist and bringing it to consultations—legitimate providers will respect a prepared patient.
The core questions apply to both surgical and non-surgical (filler) consultations, though some specifics differ. A thorough consultation should take 45–90 minutes. If a provider is rushing toward a booking decision in under 20 minutes, that itself constitutes a red flag.
Phase 1: Credential Verification (Questions 1–5)
Credentials in this field present unique complexity. “Cosmetic surgery” is not an ABMS-recognized board specialty, meaning providers can legally perform these procedures without urology or plastic surgery board certification.
Relevant board certifications include urology (AUA-affiliated), plastic and reconstructive surgery, and dermatology. “Cosmetic surgery” certifications from non-ABMS bodies carry significantly less weight.
Procedure volume matters substantially. A provider who has performed 15,000+ procedures operates with a fundamentally different risk profile than one who has performed 50.
The 5 Credential Questions to Ask
Question 1: “What is your board certification, and which ABMS-recognized board issued it?”
Listen for: Urology, plastic surgery, or dermatology. Exercise caution with vague “cosmetic surgery” certifications.
Question 2: “How many of this specific procedure have you personally performed, and over what time period?”
Context: Volume and recency both matter. Five hundred procedures over 10 years differs significantly from 500 over 2 years.
Question 3: “Do you have specialized fellowship or advanced training in male genital anatomy or sexual medicine?”
Red flag: A provider who lists only general aesthetic training for a procedure involving complex vascular and neural anatomy.
Question 4: “Is this procedure performed in an accredited surgical facility or office setting, and what accreditation does the facility hold?”
Context: Accredited ambulatory surgical centers maintain higher safety standards than non-accredited offices.
Question 5: “Can you provide references to peer-reviewed publications or professional society memberships that reflect your expertise in this area?”
Red flag: A provider who cites only their own clinic’s testimonials and marketing materials.
Phase 2: Procedure Specifics and Material Transparency (Questions 6–10)
Material transparency is non-negotiable. Providers marketing “permanent injections” using vague or proprietary terms without clear documentation of what is being injected represent a documented red flag—such materials may migrate, harden, or prove impossible to correct.
Hyaluronic acid (HA) filler represents 78% of all injectable dermal fillers globally for penile girth enhancement and remains the only injectable option reversible with hyaluronidase—a critical safety distinction.
Data presented at the 2025 AUA meeting showed that among nearly 500 men receiving HA filler, all complications were minor (Clavien-Dindo Grade 1–2), with only 0.42% experiencing injection site infections.
Decoding FDA-Cleared vs. FDA-Approved vs. Off-Label: What Every Patient Must Know
FDA-cleared (510(k)) means the device is substantially equivalent to a predicate device already on the market—not that it has been proven safe and effective through clinical trials. The Penuma silicone implant is currently the only FDA-cleared penis enlargement device for commercial use.
FDA-approved means the product has undergone rigorous clinical trial review for a specific indication. Most injectable fillers (HA, PMMA, PLA) are FDA-approved for facial use.
Off-label use occurs when an FDA-approved product is used for a purpose not included in its approved labeling. All injectable fillers used for penile girth enhancement constitute off-label use of FDA-approved cosmetic products—legal and common in medicine, but patients must be explicitly informed.
The provider should cite peer-reviewed data supporting the specific off-label application, not merely the product’s facial approval.
The 5 Material and Procedure Questions to Ask
Question 6: “What is the exact name and manufacturer of the filler or material you will use?”
Red flag: “Proprietary blend,” “our special formula,” or refusal to name the product.
Question 7: “Is this material reversible, and if so, how? If it is permanent or semi-permanent, what does correction look like if I am unhappy?”
Context: HA fillers are reversible with hyaluronidase; PMMA is not reversible.
Question 8: “Is this an FDA-cleared, FDA-approved, or off-label application? Can you show me the peer-reviewed data supporting this specific use?”
Red flag: A provider who claims FDA approval for penile-specific filler use.
Question 9: “What are the realistic girth gains I can expect in both flaccid and erect states, and do you have outcome data to support those numbers?”
Context: Many procedures improve flaccid appearance significantly more than erect size.
Question 10: “Will this be a single session or a staged approach, and what is the clinical rationale for that decision?”
Context: Staged treatments generally produce better symmetry and lower complication rates.
Phase 3: Psychological Screening — The Questions Most Men Don’t Know to Ask (Questions 11–15)
Asking about psychological screening is not an admission of mental illness—it marks a sophisticated patient who understands that ethical providers follow evidence-based protocols.
Approximately 12% of the male population perceives their penis to be small, yet the vast majority of men seeking enlargement have anatomically normal penile size. Body Dysmorphic Disorder (BDD) rates in specialized cosmetic surgery clinics range from 13–20%.
Penile Dysmorphic Disorder (PDD), a subset of BDD, is characterized by excessive preoccupation with perceived penile inadequacy. Cosmetic surgery on BDD patients is associated with poor outcomes and increased patient dissatisfaction.
The EAU 2023 Guidelines recommend that patients with normal penile size seeking augmentation be referred for psychological evaluation for potential dysmorphophobic disorders before any procedure.
How to Ask About Psychological Screening Without Feeling Stigmatized
Patients can reframe the conversation: “I’ve read that reputable providers use psychological screening tools—can you walk me through your protocol?” This positions the question as an evaluation of the provider rather than a self-disclosure.
The SMSNA position statement explicitly advocates for psychological evaluation before cosmetic penile enhancement. Only an estimated 3.6% of men who perceive themselves as having a small penis ultimately seek enhancement procedures—those who proceed are typically highly motivated and have thought carefully about this decision.
The 5 Psychological Screening Questions to Ask
Question 11: “Does your practice screen patients for Body Dysmorphic Disorder or Penile Dysmorphic Disorder before proceeding? What tool or protocol do you use?”
Listen for: Mention of COPS-P, BDD screening, or referral pathways.
Question 12: “What percentage of your consultation patients do you decline to treat, and what are the most common reasons?”
Context: A 5–15% decline rate suggests genuine evaluation.
Question 13: “Do you have a mental health professional on your team or a referral network?”
Red flag: No relationship with any mental health professional.
Question 14: “How do you assess whether a patient’s expectations are realistic?”
Listen for: Structured expectation-setting processes and standardized measurements.
Question 15: “What is your protocol if a patient is dissatisfied with results that are objectively within the normal outcome range?”
Phase 4: Risk Assessment and Complication Protocols (Questions 16–20)
The BAUS 2026 consensus document, synthesizing 36 studies (n=3,748), found injectable fillers produce short-term girth gains with mild, transient complications when performed correctly. The “when performed correctly” qualifier represents the critical variable.
Many complications stem not from the procedures themselves but from practitioners without specialized urologic training performing them.
The 5 Risk and Complication Protocol Questions to Ask
Question 16: “What are the most serious complications associated with this specific procedure, and what is your documented rate for each?”
Red flag: “We’ve never had a serious complication.”
Question 17: “What is your protocol if I develop a complication—who manages it, where, and at what cost to me?”
Question 18: “Do you perform a pre-procedure evaluation including penile measurements, hormone profile, and ultrasound?”
Context: A complete evaluation should include medical history, psychiatric and psychosexual evaluation, physical examination with measurements, biochemical profiles, and ultrasound.
Question 19: “What are the contraindications that would prevent you from performing this procedure on me?”
Question 20: “Have you ever had a patient experience a serious adverse event? How was it managed?”
Phase 5: The Ethics Test — What Happens If a Patient Is Unhappy? (Questions 21–23)
A provider’s answer to “What happens if a patient is unhappy with the result?” reveals more about their ethics than any credential. This question forces disclosure of revision policies, financial incentives, and genuine commitment to patient outcomes.
The 3 Ethics and Outcome Questions to Ask
Question 21: “What is your written policy if I am unhappy with my results? Under what circumstances would you offer revision, and at what cost?”
Question 22: “Can you show me peer-reviewed outcome data—not clinic-produced testimonials—that supports the results you’re describing?”
Question 23: “Do you have a financial relationship with the filler manufacturer or device company whose product you’re recommending?”
Phase 6: Post-Procedure Planning and Long-Term Management (Questions 24–27)
Recovery timelines and maintenance schedules should be discussed before any commitment is made. Non-surgical filler recovery typically allows patients to resume sexual activity within 7–10 days; surgical procedures typically require avoiding intense exercise for 30 days and sexual activity for 60 days.
HA fillers typically last 18–24 months. Patients should understand the long-term cost and commitment before the first procedure.
The 4 Post-Procedure Planning Questions to Ask
Question 24: “What is the detailed recovery timeline, and what specific restrictions apply?”
Question 25: “What does the long-term maintenance plan look like—how often will touch-ups be needed, and what will they cost?”
Question 26: “What follow-up appointments are included in the procedure cost?”
Question 27: “Do you work with or refer to urologists, sexual medicine specialists, or mental health professionals as part of ongoing care?”
Red Flag Summary: The 10 Warning Signs That Should End a Consultation
- Provider cannot name their ABMS-recognized board certification
- Provider cannot name the specific filler product or uses “proprietary blend”
- Provider claims filler is “FDA-approved for penile use”
- No psychological screening protocol exists
- Provider claims zero adverse events across thousands of procedures
- No written revision or complication management policy
- Provider relies exclusively on clinic-produced testimonials
- Consultation is rushed with pressure toward immediate booking
- Procedure will be performed in a non-accredited facility
- Provider has no relationship with mental health professionals or urologic specialists
What a Best-in-Class Consultation Looks Like
A gold-standard consultation takes 45–90 minutes, includes physical examination with measurements, reviews medical and psychosexual history, uses validated screening tools, and provides written documentation of all discussed risks, materials, and policies.
Written informed consent should explicitly name the material being used, its regulatory status, the specific risks discussed, the revision policy, and the realistic outcome range.
Stoller Medical Group’s approach—staged treatments, conservative planning, thorough consultations, and a non-surgical focus—reflects many of these best-practice elements, including the decision not to offer higher-risk surgical lengthening procedures.
Conclusion: The Consultation Is the Procedure
The quality of the consultation is the single most predictive variable in outcome—more than the procedure type, the filler brand, or the marketing claims. A provider’s answer to “What happens if a patient is unhappy with the result?” remains the most revealing question in this checklist.
Because no major medical organization formally endorses cosmetic penile enlargement for men with normal anatomy, the burden of due diligence falls on the patient. This checklist provides the framework to meet that burden with the same rigor applied to any significant professional or financial decision.
Ready to Ask These Questions in Person? Schedule a Consultation With Stoller Medical Group
For those ready to put these questions to a provider, Stoller Medical Group—with 15,000+ procedures performed and locations across New York, Pennsylvania, and Minnesota—is designed to answer all of them.
Dr. Roy B. Stoller is board-certified with 25+ years in aesthetic medicine and five years dedicated specifically to non-surgical male enhancement. The practice uses named, documented filler products, staged treatment protocols are standard, and free consultations are available.
The practice’s decision not to offer surgical penile lengthening due to higher associated risks is itself an answer to Question 19—and it reflects the appropriate clinical standard.
Locations include Manhattan (515 Madison Avenue), Long Island (Jericho), Albany (Latham), Pennsylvania (Chadds Ford), and Minnesota (Eagan), with free consultations available at all locations.
Bringing this checklist to a consultation is encouraged. A provider worth trusting will welcome every question on it.
